AI-generated summary
The authors compared intravascular laser irradiation of blood using red light (650 nm) and blue light (415 nm) in 30 post-stroke patients in a double-blind, randomized, crossover trial. They report that red-light treatment was associated with reductions in red blood cell count, hematocrit and fibrinogen, while both wavelengths were associated with improved motor and balance scores without significant between-group differences. Findings were stratified by age and need further study in larger, longer trials.
- Participants
- 30
- Who or what was studied
- Patients within 6 months after stroke
- Wavelengths
- 650, 415 nm
- Limits stated in the abstract
- The abstract describes a small sample, age-stratified subgroup analyses, and states that the findings warrant investigation in larger and longer-term studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm, 415 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Stroke, Laser, Randomized controlled trial, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.